Life Sciences
at Vistatec
Translation and localization for essential medical services.
Life Sciences
at Vistatec
Translation and localization for essential medical services.
The Vistatec dedicated Life Sciences Division understands the importance of specialized workflows and expertise to deliver solutions for leading organizations worldwide.
Our clients benefit from accurate and high-quality solutions, with industry-leading expertise demonstrated across a portfolio that includes medical devices, health care software, clinical trials, biotechnology, mental health, pharmaceuticals, and pure and applied science.
We provide multilingual support at every stage of the product life cycle.
Join the new Life Sciences Newsletter
Gain access to exclusive resources, case studies and success stories, interviews with localization leaders and more.
Life Sciences Podcasts
Catch up on the latest episodes of our Life Sciences — In Focus Podcast. View the videos below, or visit the show page on Spotify, YouTube, or Apple Podcasts.
In this episode, Alec McChesney, Director of Business Development at life sciences-focused SCORR Marketing, joins Host Karen Tkaczyk. Alec’s passion for strategic marketing in the life sciences shone through in a thought-provoking and practical conversation. From the importance of personalized campaigns to navigating global regulatory landscapes, Alec offered insights on how life sciences companies can thrive in a competitive and ever-changing market.
Watch Previous Episodes:
Life Sciences Events
Life Sciences — In Focus Panel Discussions
Ep 5: Breaking Barriers: Enhancing Diversity and Inclusion in Clinical Research
Clinical research holds the key to groundbreaking treatments and improved health outcomes. But for far too long, it has struggled to represent the people it aims to serve—particularly underserved communities. A recent Life Sciences – In Focus panel discussion titled “Breaking Barriers: Enhancing Diversity and Inclusion in Clinical Research” shed light on these systemic issues while offering innovative, practical solutions to create more equitable and inclusive trials.
Ep 4: FDA Diversity Action Plans: Deciphering the Guidance and its Consequences
The US Food and Drug Administration has released long-awaited updated guidance on Diversity Action Plans. This guidance is stronger and very specific in places. In this panel discussion, Vistatec invites industry-leading experts Aman Khera, Joan A. Chambers, and Lya Rebelo to explore how both large and small sponsors are responding to these changes. Through real-world examples, they discuss the implications of these plans on site burden, patient experience, and how clinical operations and regulatory affairs teams are applying this US-focused guidance in global trials. Click the video to watch the recording of this essential conversation.
Ep 3: Navigating the Regulatory Landscape - Latin America Edition
Through case studies and real-world examples, learn from success stories and lessons gained from navigating the complex regulatory environment in Latin America. Vistatec invited industry-leading experts to share the latest regulatory updates and trends and understand their implications for clinical research and development. Click the video to watch the recording of the panel discussion.
Ep 2: Real-World Evidence: Global Regulatory Landscape and Innovation
Real-world evidence (RWE) has been a hot topic in recent years, not only in the research and life sciences industry but also in public health. Given the challenges surrounding its ethical use and regulation, the increasing importance of AI and the sheer volume of data available, the discussion is sure to continue. Vistatec invited industry-leading experts to share their insights, thoughts, and predictions on the role of RWE going forward. Click the video to watch the recording of the panel discussion, or read the key learnings here.
Ep 1: Leveraging Data and Trends for 2024
In the first installment of Vistatec’s Life Sciences – In Focus series, Amanda Murphy, Senior Director of Data Intelligence and Solutions at GlobalData, presented the biopharmaceutical industry’s outlook for 2024. The event yielded valuable insights into the trends and themes predicted for the upcoming year, focusing on the clinical trials landscape, including decentralized clinical trials and diversity. Click the video to watch the recording, or read the key learnings from the event here.
Latest Life Sciences Articles
Our Expertise
Life Sciences Industry
Where the world’s greatest minds are working simultaneously for the betterment of the human race.
Life Sciences Translation
Our life science localization experts are constantly adapting and evolving with the industry.
Compliance
Additional ISO Certifications
ISO 9001:2015 Quality Management System | ISO 17100:2015 Translation Service Providers standards
ISO 27001:2013 Information Security | ISO 18587:2017 Machine translation post-editing
Life Sciences Experts
Kara Bolt
Director
Life Sciences Division
Karen Tkaczyk, PhD
Director of Sales
Life Sciences Division
Maria Mateos
Strategic Account Director
Life Sciences Division
Erin Nye, Illumina
Think Global Forum
Richard Korn, Edward Life Sciences
Sean Kinsell, Medidata